Dian Qu

Analyst, China Research
+44 20 3137 7263

Jonathan Fenby

Chairman, China team and Managing Director, European Political Research
+44 20 7246 7880

How can we help?

To learn more about our services get in touch on +44 20 7246 7800 or sales@trustedsources.co.uk.

Recent China research

* China Watch: MSCI doesn’t drive inflows, reform does, Michelle Lam, Trey McArver, Oliver Brennan, 22 Jun 2017
* China Watch: The tide is slowly turning, Michelle Lam, Trey McArver, Larry Brainard, 15 Jun 2017
* Trump’s Korea play stalls, Jonathan Fenby, 15 Jun 2017
* China Watch: China’s FX policy and the dollar, Michelle Lam, Trey McArver, Larry Brainard, 8 Jun 2017
* Can the US win in China’s LNG market?, Stephen O'Sullivan, 8 Jun 2017

See all our China research >>

The reality behind China’s healthcare prescription

Overview

China’s plan to provide universal health care is an essential element in its broader policy of economic rebalancing in order to boost domestic demand and lessen export dependency. Since its launch in 2009 the programme has met some of its official goals and has been bolstered by significant shifts in central government funding policies. Healthcare sector stocks have soared as a result, particularly in expectation of greatly increased demand for pharmaceuticals and medical equipment....

* Access to this publication is restricted

Request access

If you would like to read this publication, please enter your name and email address below:

Alternatively please call us on +44 20 7183 5280, or email sales@trustedsources.co.uk.

Already registered?